HOTH News and Press, Hoth Therapeutics Inc.

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X (SOXS) rose 3.8% to $6.53 on volume of 524,370,795 shares BioRestorative Therapies Inc (BRTX) rose 73.3% to $0.4329 on volume of 509,646,368 shares AIM ImmunoTech Inc. (AIM) rose 72.4% to $0.4011 on ...

Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications PR Newswire Company Adopts Space-Focused Identity, New Tic...

Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform PR Newswire Allowed Claims Cover Composition-of-Matter and Methods Targeting MS4A6A Pre-mRNA Splicing to Reduce Surface Expression of the High-Affinity IgE Receptor (FcεRI); Strengthens Intell...

AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanomagnetic Semiconductor Architecture P...

Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients PR Newswire Regulatory Clearance in Spain Advances Randomized,  Placebo-Controlled Study; Patients Show Meaningful Reductions in EGFR-In...

2026-04-14 08:29:07 ET Denver, Colorado - Hoth Therapeutics (NASDAQ:HOTH) is stepping into one of the most competitive, and lucrative, arenas in biotech with data that suggests a fundamentally different approach to treating metabolic disease. Rather than simply helping patients lose weight,...

Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide PR Newswire Statistically Significant Reduction in Srebf1 (Fat Production) and Increased Ppa...

Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering PR Newswire NEW YORK , April 2, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical need...

Hoth Therapeutics Announces $2.0 Million Registered Direct Offering PR Newswire NEW YORK , April 1, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs, today an...

Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week Six PR Newswire Over 65% of Patients Reported Reduced Pain and Itching; Zero Disruptions to EGFR Cancer Therapy with ~99% Lower Systemic Exposure ...